Latham Advises CVC on Sale of Minority Stake in Rayner

Latham & Watkins has advised CVC, one of the world’s leading private markets investment firms, on the sale of a minority stake in Rayner, a global leader in ophthalmic innovation, to investment holding company GBL.

GBL will invest €0.5 billion of equity to acquire a co-controlling minority stake in Rayner from CVC Capital Partners VIII. CVC will partner with GBL and Rayner’s management team to support Rayner in its international growth ambitions.

The Latham team was led by London partners Ross Allardice and Jon Fox, with associates Benedict Tansey, Vivian Yeung, Aslihan Alparslan, Kat Yeung, and Thomas Farrell. Advice was also provided on finance matters by London partner Charles Armstrong, with associates Khayam Amin and Charlotte Hoggarth; on tax matters by London partner Helen Lethaby, with associate Joshua James Atkinson; on healthcare and life sciences matters by London partner Lydia Torne, with Paris associate Grégoire Paquet, and Washington, D.C. associate Meryl Bartlett; on data and technology matters by London partner Gail Crawford, with associates Oluyinka (Yinka) Ogboye, San Thiri (Christine) Tun, Callum Lee, and Annabel Loose; and on compliance matters by Los Angeles partner Joshua Hamilton, with counsel Greg Swartz, and associate Sara Mae Turk.